Class information for:
Level 1: LOVASTATIN//BB BIOCYT//PEDIAT PNEUMONOL ALLERG DIS HEMATOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9022 1128 45.6 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
408 16067 STATINS//EZETIMIBE//SIMVASTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LOVASTATIN Author keyword 11 11% 8% 92
2 BB BIOCYT Address 4 75% 0% 3
3 PEDIAT PNEUMONOL ALLERG DIS HEMATOL Address 4 75% 0% 3
4 HYDROXYMETHYLGLUTARYL COA REDUCTASE INHIBITORS Author keyword 3 11% 2% 23
5 3 HYDROXY 3 METHYL GLUTARYL COA Author keyword 1 50% 0% 2
6 3 HYDROXY 3 METHYL GLUTARYL COENZYME A HMG COA REDUCTASE INHIBITORS Author keyword 1 100% 0% 2
7 3 HYDROXY 3 METHYL GLUTARYL COENZYME A INHIBITORS Author keyword 1 100% 0% 2
8 BOSTON MAV 151 Address 1 100% 0% 2
9 INTERNAL DIS HYPERTENS VASC DIS Address 1 50% 0% 2
10 KAISER RIVERSIDE MED Address 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LOVASTATIN 11 11% 8% 92 Search LOVASTATIN Search LOVASTATIN
2 HYDROXYMETHYLGLUTARYL COA REDUCTASE INHIBITORS 3 11% 2% 23 Search HYDROXYMETHYLGLUTARYL+COA+REDUCTASE+INHIBITORS Search HYDROXYMETHYLGLUTARYL+COA+REDUCTASE+INHIBITORS
3 3 HYDROXY 3 METHYL GLUTARYL COA 1 50% 0% 2 Search 3+HYDROXY+3+METHYL+GLUTARYL+COA Search 3+HYDROXY+3+METHYL+GLUTARYL+COA
4 3 HYDROXY 3 METHYL GLUTARYL COENZYME A HMG COA REDUCTASE INHIBITORS 1 100% 0% 2 Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+HMG+COA+REDUCTASE+INHIBITORS Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+HMG+COA+REDUCTASE+INHIBITORS
5 3 HYDROXY 3 METHYL GLUTARYL COENZYME A INHIBITORS 1 100% 0% 2 Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+INHIBITORS Search 3+HYDROXY+3+METHYL+GLUTARYL+COENZYME+A+INHIBITORS
6 SIMVASTATIN SVA 1 100% 0% 2 Search SIMVASTATIN+SVA Search SIMVASTATIN+SVA
7 2 3 CYCLIC NUCLEOTIDE 3 PHOSPHODIESTERASE CNP 1 50% 0% 1 Search 2++3++CYCLIC+NUCLEOTIDE+3++PHOSPHODIESTERASE+CNP Search 2++3++CYCLIC+NUCLEOTIDE+3++PHOSPHODIESTERASE+CNP
8 AH136B 1 50% 0% 1 Search AH136B Search AH136B
9 ANDROGEN RESPONSE GENES 1 50% 0% 1 Search ANDROGEN+RESPONSE+GENES Search ANDROGEN+RESPONSE+GENES
10 CANCER CELL SIGNALLING 1 50% 0% 1 Search CANCER+CELL+SIGNALLING Search CANCER+CELL+SIGNALLING

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LOVASTATIN INDUCED APOPTOSIS 87 65% 7% 84
2 CHOLESTEROL LOWERING DRUGS 39 61% 4% 41
3 TUMOR SPECIFIC APOPTOSIS 33 77% 2% 23
4 LOVASTATIN 22 11% 17% 187
5 STATIN USE 18 24% 6% 66
6 MEVALONATE PATHWAY 17 13% 11% 128
7 LOVASTATIN INDUCES APOPTOSIS 10 73% 1% 8
8 POTENTIATES ANTITUMOR ACTIVITY 10 73% 1% 8
9 PRAVASTATIN USE 9 83% 0% 5
10 STATINS ACTIVATE 9 83% 0% 5

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis 2013 59 52 42%
Statin use and cancer risk: a comprehensive review 2010 74 94 74%
HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence? 2015 1 102 65%
Statins and cancer: Current and future prospects 2012 49 157 72%
Novel prospects of statins as therapeutic agents in cancer 2014 8 187 74%
The statins as anticancer agents 2003 306 87 48%
Statins in tumor suppression 2008 83 82 70%
Statins and cancer prevention 2005 335 106 47%
Statins and cancer: A systematic review and meta-analysis 2008 135 69 46%
Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis 2013 19 44 66%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BB BIOCYT 4 75% 0.3% 3
2 PEDIAT PNEUMONOL ALLERG DIS HEMATOL 4 75% 0.3% 3
3 BOSTON MAV 151 1 100% 0.2% 2
4 INTERNAL DIS HYPERTENS VASC DIS 1 50% 0.2% 2
5 KAISER RIVERSIDE MED 1 100% 0.2% 2
6 ST MED 1 100% 0.2% 2
7 ENDERS S 1 23% 0.4% 5
8 BIOSTAT EPIDEMIOL EDUC THER EUT 1 40% 0.2% 2
9 INTERUNIV PHLEBOLYMPHOL 1 40% 0.2% 2
10 BIOL ECOL SCI 1 13% 0.5% 6

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000126886 P DIS TB INTERNAL MED//3 HYDROXY 3 METHYLGLUTARYL CO ENZYME A REDUCTASE INHIBITOR//INTER PROGRAM IMMUNOL
2 0.0000104845 ASSOC CARDIAC//ASSOC RIC CARDIOL//CLIN EXPT MED 2
3 0.0000102373 FLUVASTATIN//PLEIOTROPIC EFFECTS//HMG COA REDUCTASE INHIBITOR
4 0.0000097958 FOOD FUS COMPLEX//KARMELLAE//HYPOCHOLESTEROLEMIC PEPTIDE
5 0.0000093609 PERILLYL ALCOHOL//DIETARY ISOPRENOIDS//APOMINE
6 0.0000083168 STATIN MYOPATHY//STATIN INTOLERANCE//MYALGIA
7 0.0000079427 FARNESYLTRANSFERASE//FARNESYL TRANSFERASE INHIBITOR//FARNESYL TRANSFERASE INHIBITORS
8 0.0000063229 INTRAMEMBRANOUS BONE GRAFT//ORTHOPEDORTHOPED SURG//AORTIC CALCIFICATION
9 0.0000055875 HEMISPHERIC CHEMICAL DOMINANCE//MEMBRANE NA K ATPASE//DOLICHOL
10 0.0000053899 LOW DENSITY LIPOPROTEIN LDL RECEPTORS//ATHEROGENIC MICE//BIOCHEM BIOPHYS S